Blood type B was linked with breast carcinomas that exhibited overexpression of the human epidermal growth factor receptor HER2 (p < 0.05) and a heightened risk of cancer onset after the age of 70 (p < 0.001). The gene discussed is ERBB2; the disease is breast carcinoma.